A randomized controlled study of ramipril alone and ramipril combined with pycnogenol in the treatment of MetS found that the combined treatment group decreased urinary albumin more significantly than the control group, and the renal cortical blood flow rate and renal function improved more significantly (123). The gene discussed is ALB; the disease is metabolic syndrome.